Biocartis Group NV: Invitation to Annual Shareholders’ Meeting

    NEXT STORY
    PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)
    PREV STORY
    Epizyme Announces Publication of Tazemetostat Phase 1 Clinical Data in The Lancet Oncology
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    XBiotech to Present at Cantor Fitzgerald’s Global Healthcare Conference

    AUSTIN, Texas, Sept. 21, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that ...

    author_avatar
    NASDAQ Market News

    Press news Biocartis Group NV: Disclosure of a transparency notification

    author_avatar
    NASDAQ Market News

    Santhera to Present Long-term Efficacy Results with Idebenone in DMD at the 2019 MDA Clinical and Scientific Conference

    author_avatar
    NASDAQ Market News